
The Merck Manual Professional Version provides health care practitioners and students with practical explanations of what to do to diagnose and treat conditions in all of the major medical and surgical specialties. It covers when to suspect a disease, a sequence of evaluation, and treatment options along with selected alternatives. In addition, it provides enough background information on etiology and pathophysiology to ensure comprehension of the management recommendations.
In 2015, The Merck Manuals embarked on its most aggressive and far-reaching medical knowledge initiative to date, Global Medical Knowledge 2020. Through this worldwide project, The Merck Manuals aims to make the best current medical information accessible by more than 3 billion health care professionals and patients around the world by 2020. As part of this project, all Merck Manuals translations will be available online and kept current with the English version.
Editorial Independence:
The Merck Manual is published by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., as a service to the medical community. It is the product of a collaboration between hundreds of medical experts worldwide, an independent editorial board of peer reviewers, and the Merck Manuals editorial staff of physicians and professional medical writers. For over 100 years, The Manual has had complete editorial independence to present the best current thinking regarding medical diagnosis and treatment, and does not in any way promote or publicize Merck products. To ensure absence of commercial or corporate bias, authors and peer reviewers cannot be Merck employees, nor can they serve as speakers for Merck products, or in any other way represent the company. Although the editorial staff is employed by Merck, there is no control, review, or even input into the content of The Manuals allowed from any other part of Merck, including research and development, sales and marketing, public relations, legal, and corporate management.
Privacy:
Merck may collect information about you, such as your name and/or user name and the comments you post, to understand and address perspectives about our company mission, strategy, practices, developments within our business and in healthcare and for legal and regulatory purposes. For more information about Merck's privacy practices, please read our Privacy Commitment here: http://www.merck.com/privacy/. To find out about how Facebook uses your information, click here: http://www.facebook.com/about/privacy/.
In 2015, The Merck Manuals embarked on its most aggressive and far-reaching medical knowledge initiative to date, Global Medical Knowledge 2020. Through this worldwide project, The Merck Manuals aims to make the best current medical information accessible by more than 3 billion health care professionals and patients around the world by 2020. As part of this project, all Merck Manuals translations will be available online and kept current with the English version.
Editorial Independence:
The Merck Manual is published by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., as a service to the medical community. It is the product of a collaboration between hundreds of medical experts worldwide, an independent editorial board of peer reviewers, and the Merck Manuals editorial staff of physicians and professional medical writers. For over 100 years, The Manual has had complete editorial independence to present the best current thinking regarding medical diagnosis and treatment, and does not in any way promote or publicize Merck products. To ensure absence of commercial or corporate bias, authors and peer reviewers cannot be Merck employees, nor can they serve as speakers for Merck products, or in any other way represent the company. Although the editorial staff is employed by Merck, there is no control, review, or even input into the content of The Manuals allowed from any other part of Merck, including research and development, sales and marketing, public relations, legal, and corporate management.
Privacy:
Merck may collect information about you, such as your name and/or user name and the comments you post, to understand and address perspectives about our company mission, strategy, practices, developments within our business and in healthcare and for legal and regulatory purposes. For more information about Merck's privacy practices, please read our Privacy Commitment here: http://www.merck.com/privacy/. To find out about how Facebook uses your information, click here: http://www.facebook.com/about/privacy/.
Location: United States, New Jersey, Rahway
Mentions in press and media 33
Date | Title | Description |
03.02.2025 | Dr. Michael T. Burcon Presenting at ARO Meniere's Disease Symposium at 48th Annual MidWinter Meeting, Monday, February 24, 8am, in Orlando, FL | Surgery for Chiari Malformation causing daily Migraines and weekly Meniere's attacks Dr. Burcon will be presenting his paper, "Inner Ear Fluids Imbalance in Meniere's Disease Between Blood and Cerebrospinal Fluid," discussing his ... |
09.09.2024 | Ten Times to Try Telehealth from Trusted Medical Reference: MerckManuals.com | Telehealth Is Convenient Telehealth provides patients with options to connect with their healthcare providers when a virtual visit can provide the care a patient needs and is more convenient, feasible, or safe than an in-person appointment.... |
09.09.2023 | Kick Streamer Goes Live for 164 Hours Straight Without Sleep, Shatters World Record | John Lopez, Tech Times 09 September 2023, 10:09 am Kick streamer 'GiftedPrime' has gone where few dared to venture, breaking the Guinness World Record for the longest live stream without sleep, clocking an astounding 164 hours live without ... |
21.07.2023 | Hair-loss treatments that don't require surgery and actually work, according to doctors | Health Hair-loss treatments that don't require surgery and actually work, according to doctors Hilary Brueck 2023-07-21T17:30:00Z Share icon An curved arrow pointing right. Share Facebook Icon The letter F. Facebook Email icon An envelope. ... |
07.02.2023 | J&J Drug for Rare Infant Blood Disorder Achieves Main Goal of Phase 2 Test | Johnson & Johnson drug nipocalimab is in late-stage clinical testing in a rare neuromuscular disorder, and if it stays on track could become the third-to-market drug in its class for that indication. But the pharmaceutical giant now has... |
06.02.2023 | Breaking News | Today’s Veterinary Business Staff Read Articles Written by Today’s Veterinary Business Staff SignalPET Expands Overseas SignalPET, whose AI-backed software helps clinicians quickly interpret veterinary radiographs, is expanding into Hong Ko... |
02.02.2023 | Merck Manuals Introduces New Resources on One Health Approach | “The One Health approach bridges the gap between human and animal medicine,” said Melissa Adams, director of marketing and brand awareness for the Merck Manuals. “Moreover, it recognizes the role the environment plays in promoting well-bein... |
05.10.2022 | I've treated people with dissociative identity disorder for 26 years – here are 6 myths I want to clear up | Reviews Chevron icon It indicates an expandable section or menu, or sometimes previous / next navigation options. Health I've treated people with dissociative identity disorder for 26 years – here are 6 myths I want to clear up Written by R... |
20.04.2022 | 20220420-gender-dysphoria-guidance | Contact: Communications Office NewsMedia@flhealth.gov 850-245-4111 The Florida Department of Health wants to clarify evidence recently cited on a fact sheet released by the US Department of Health and Human Services and provide guidance on ... |
07.10.2021 | Merck Manuals Survey: More Than Two Thirds of Americans Often Hear Conflicting Medical Information from Family and Friends | KENILWORTH, N.J., Oct. 7, 2021 /PRNewswire/ -- Patients and medical professionals have access to unprecedented amounts of medical information, but evaluating the quality of information and using it to make informed health choices remains di... |
Show more